Mesothelioma research paper
Dr Nikolaos Kanellakis recently published a study on mesothelioma in . the journal of British Thoracic Society. He is the first author of the , while Dr , Supernumerary Fellow in Medicine and Director of the Oxford Respiratory Trials Unit, is the senior. They collaborated with who is also a Supernumerary Fellow in Medicine.
Mesothelioma is an aggressive malignancy and currently there are not available biomarker guided treatments. The study established and characterised a panel of patient derived mesothelioma cell lines. It is a faithful translational model of the disease and could be used to develop guided treatments.
Dr Nikolaos I. Kanellakis has been appointed as a Stipendiary Lecturer in Pathology. He is currently a ‎postdoctoral researcher in the ‎Nuffield Department of Medicine. His research focuses on pleural malignancies and diseases.
Published: 20 October 2020